Literature DB >> 26149495

Glutathione Depletion Accelerates Cigarette Smoke-Induced Inflammation and Airspace Enlargement.

Neal S Gould1, Elysia Min2, Jie Huang2, Hong Wei Chu3, Jim Good2, Richard J Martin4, Brian J Day5.   

Abstract

The study objective was to assess age-related changes in glutathione (GSH) adaptive response to cigarette smoke (CS) exposure. Older cigarette smokers show a decline (67%) in lung epithelial lining fluid (ELF) GSH and a 1.8-fold decreased GSH adaptive response to cigarette smoking with a concomitant elevation (47%) of exhaled nitric oxide compared with younger smokers. In order to isolate the changes in tissue GSH from other age-related effects, pharmacological inhibition of the rate limiting step in GSH synthesis was employed to examine the lung's response to CS exposure in young mice. The γ-glutamylcysteine ligase inhibitor L-buthionine-sulfoximine (BSO) was administered in the drinking water (20 mM) to decrease by half the in vivo GSH levels to those found in aged mice and humans. Mice were then exposed to CS (3 h/day) for 5 or 15 days. Biochemical analysis of the ELF and lung tissue revealed an inhibition of the CS-induced GSH adaptive response by BSO with a concurrent increase in mixed protein-GSH disulfides indicating increased cysteine oxidation. The prevention of the GSH adaptive response led to an increase in pro-inflammatory cytokines present in the lung. Airspace enlargement is a hallmark of lung emphysema and was observed in mice treated with BSO and exposed to CS for as little as 15 days, whereas these types of changes normally take up to 6 months in this model. BSO treatment potentiated both lung elastase and matrix metalloproteinase activity in the CS group. These data suggest that age-related decline in the GSH adaptive response can markedly accelerate many of the factors thought to drive CS-induced emphysema.
© The Author 2015. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  agents; antioxidants; inhalation toxicology; oxidative injury; respiratory toxicology; systems toxicology

Mesh:

Substances:

Year:  2015        PMID: 26149495      PMCID: PMC4707200          DOI: 10.1093/toxsci/kfv143

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  53 in total

Review 1.  Redox sensing by proteins: oxidative modifications on cysteines and the consequent events.

Authors:  Ying Wang; Jie Yang; Jing Yi
Journal:  Antioxid Redox Signal       Date:  2011-12-19       Impact factor: 8.401

2.  Plasma antioxidants are associated with impaired lung function and COPD exacerbations in smokers.

Authors:  Michael E Nicks; Maureen M O'Brien; Russell P Bowler
Journal:  COPD       Date:  2011-06-01       Impact factor: 2.409

3.  Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice.

Authors:  Tirumalai Rangasamy; Chung Y Cho; Rajesh K Thimmulappa; Lijie Zhen; Sorachai S Srisuma; Thomas W Kensler; Masayuki Yamamoto; Irina Petrache; Rubin M Tuder; Shyam Biswal
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

Review 4.  Exhaled nitric oxide in pulmonary diseases: a comprehensive review.

Authors:  Peter J Barnes; Raed A Dweik; Arthur F Gelb; Peter G Gibson; Steven C George; Hartmut Grasemann; Ian D Pavord; Felix Ratjen; Philip E Silkoff; D Robin Taylor; Noe Zamel
Journal:  Chest       Date:  2010-09       Impact factor: 9.410

5.  Effects of the long-term depletion of reduced glutathione in mice administered L-buthionine-S,R-sulfoximine.

Authors:  J D Sun; S S Ragsdale; J M Benson; R F Henderson
Journal:  Fundam Appl Toxicol       Date:  1985-10

6.  Developing COPD: a 25 year follow up study of the general population.

Authors:  A Løkke; P Lange; H Scharling; P Fabricius; J Vestbo
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

7.  A procedure for quantitative determination of tris(2-carboxyethyl)phosphine, an odorless reducing agent more stable and effective than dithiothreitol.

Authors:  J C Han; G Y Han
Journal:  Anal Biochem       Date:  1994-07       Impact factor: 3.365

8.  Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses.

Authors:  Dean P Jones; Vino C Mody; Joanne L Carlson; Michael J Lynn; Paul Sternberg
Journal:  Free Radic Biol Med       Date:  2002-11-01       Impact factor: 7.376

9.  Macropinocytosis of extracellular glutathione ameliorates tumor necrosis factor α release in activated macrophages.

Authors:  Neal S Gould; Elysia Min; Brian J Day
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

10.  Lung glutathione adaptive responses to cigarette smoke exposure.

Authors:  Neal S Gould; Elysia Min; Steve Gauthier; Richard J Martin; Brian J Day
Journal:  Respir Res       Date:  2011-10-07
View more
  13 in total

1.  Intermittent Hypoxia Contributes to the Lung Damage by Increased Oxidative Stress, Inflammation, and Disbalance in Protease/Antiprotease System.

Authors:  I Tuleta; F Stöckigt; U R Juergens; C Pizarro; J W Schrickel; G Kristiansen; G Nickenig; D Skowasch
Journal:  Lung       Date:  2016-10-13       Impact factor: 2.584

2.  Dysregulation of the glutaredoxin/S-glutathionylation redox axis in lung diseases.

Authors:  Shi B Chia; Evan A Elko; Reem Aboushousha; Allison M Manuel; Cheryl van de Wetering; Joseph E Druso; Jos van der Velden; David J Seward; Vikas Anathy; Charles G Irvin; Ying-Wai Lam; Albert van der Vliet; Yvonne M W Janssen-Heininger
Journal:  Am J Physiol Cell Physiol       Date:  2019-11-06       Impact factor: 4.249

3.  Nuclear factor kappa-B contributes to cigarette smoke tolerance in pancreatic ductal adenocarcinoma through cysteine metabolism.

Authors:  Venugopal Gunda; Yashpal S Chhonker; Nagabhishek Sirpu Natesh; Pratima Raut; Sakthivel Muniyan; Todd A Wyatt; Daryl J Murry; Surinder K Batra; Satyanarayana Rachagani
Journal:  Biomed Pharmacother       Date:  2021-10-19       Impact factor: 6.529

4.  The Relationship Between Airway Antioxidant Levels, Alcohol Use Disorders, and Cigarette Smoking.

Authors:  Ellen L Burnham; Alicia McNally; Jeanette Gaydos; Lou Ann S Brown
Journal:  Alcohol Clin Exp Res       Date:  2016-09-14       Impact factor: 3.455

5.  Xeroderma Pigmentosum Group C Deficiency Alters Cigarette Smoke DNA Damage Cell Fate and Accelerates Emphysema Development.

Authors:  Catherine R Sears; Huaxin Zhou; Matthew J Justice; Amanda J Fisher; Jacob Saliba; Isaac Lamb; Jessica Wicker; Kelly S Schweitzer; Irina Petrache
Journal:  Am J Respir Cell Mol Biol       Date:  2018-03       Impact factor: 6.914

6.  A Drosophila model of cigarette smoke induced COPD identifies Nrf2 signaling as an expedient target for intervention.

Authors:  Ruben Prange; Marcus Thiedmann; Anita Bhandari; Neha Mishra; Anupam Sinha; Robert Häsler; Philipp Rosenstiel; Karin Uliczka; Christina Wagner; Ali Önder Yildirim; Christine Fink; Thomas Roeder
Journal:  Aging (Albany NY)       Date:  2018-08-27       Impact factor: 5.682

7.  Physical Exercise-Mediated Changes in Redox Profile Contribute to Muscle Remodeling After Passive Hand-Rolled Cornhusk Cigarette Smoke Exposure.

Authors:  Anand Thirupathi; Silvia Scarparo; Paulo L Silva; Luis F Marqueze; Franciane T F Vasconcelos; Seigo Nagashima; Eduardo B B Cunha; Lúcia de Noronha; Paulo C L Silveira; Renata T Nesi; Yaodong Gu; Ricardo A Pinho
Journal:  Front Physiol       Date:  2020-11-17       Impact factor: 4.566

8.  Crocin attenuates cigarette smoke-induced lung injury and cardiac dysfunction by anti-oxidative effects: the role of Nrf2 antioxidant system in preventing oxidative stress.

Authors:  Mahin Dianat; Maryam Radan; Mohammad Badavi; Seyyed Ali Mard; Vahid Bayati; Masoumeh Ahmadizadeh
Journal:  Respir Res       Date:  2018-04-10

Review 9.  Endoplasmic reticulum stress and glutathione therapeutics in chronic lung diseases.

Authors:  Yvonne Janssen-Heininger; Niki L Reynaert; Albert van der Vliet; Vikas Anathy
Journal:  Redox Biol       Date:  2020-03-23       Impact factor: 11.799

Review 10.  Rationale for the use of N-acetylcysteine in both prevention and adjuvant therapy of COVID-19.

Authors:  Silvio De Flora; Roumen Balansky; Sebastiano La Maestra
Journal:  FASEB J       Date:  2020-08-11       Impact factor: 5.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.